TRT and Immune Function: Understanding Interactions

Testosterone affects immune cell activity and may reduce certain inflammatory markers. Notably, this is most evident in men with a confirmed deficiency. Indeed, evidence supports this connection at the cellular level. But it does not make TRT an anti-inflammatory treatment. The effect depends on baseline hormone levels, the degree of deficiency, and other metabolic factors.

Testosterone and the Immune System: What the Connection Looks Like

When men research TRT for inflammation, they are often asking a direct question: could raising testosterone reduce the chronic aches and fatigue they have been carrying? That curiosity is not unfounded. But the answer calls for more nuance than a yes or no.

T cells, B cells, macrophages, and natural killer cells all carry androgen receptors. When testosterone binds to those receptors, it changes how immune cells produce and release signaling proteins. That is a biological fact, not a theory.

This does not mean testosterone suppresses all immune defenses or protects against infection. The effect is selective. It tends to dampen certain inflammatory signals while leaving most immune responses intact. The evidence does not support the idea that TRT broadly strengthens immunity.

Explore Subcutaneous vs Intramuscular Testosterone Injections: Which Is Better?

How Testosterone Modulates Inflammation

The Cytokine Connection: IL-6, TNF-alpha, and IL-1B

Cytokines are signaling proteins that coordinate immune responses. Some cytokines amplify inflammation when produced in excess. These include interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1 beta (IL-1B). In fact, hypogonadal men often show raised levels of all three.

Testosterone suppresses cytokine production through androgen receptor signaling in immune and fat cells. Multiple studies have reported drops in TNF-alpha and IL-1B after therapy in hypogonadal men. One 30-week trial of 113 hypogonadal men linked therapy to lower TNF-alpha and CRP. IL-6 reduction is the least consistent finding and was absent in several trials even in men with metabolic syndrome.

A 2018 review found TRT consistently reduced TNF-alpha in hypogonadal men, with CRP reductions reported across most but not all study populations. Generally, men with higher inflammation at the start of treatment show the biggest response.

CRP and Low Testosterone: What the Evidence Shows

C-reactive protein (CRP) is a widely used marker of chronic low-grade inflammation. Research into the link between low testosterone and immune system markers often finds an inverse pattern. Men with lower testosterone tend to carry higher CRP levels, even after adjusting for age and body weight.

A cross-sectional study of 149 men found that lower androgen levels correlated with higher CRP. A 2022 cross-sectional study linked higher immune-inflammation index scores to greater testosterone deficiency risk, with the strongest effects in obese men and men under 40.

Whether TRT reliably lowers CRP in all hypogonadal men is less certain. Notably, the effect is most consistent in men who are both hypogonadal and metabolically compromised. In leaner men with less baseline inflammation, the response to TRT varies.

Low Testosterone and Chronic Low-Grade Inflammation: What Comes First

TRT and chronic inflammation are not connected in a one-way chain. The relationship runs both ways, and that matters clinically.

Visceral fat builds up more easily when testosterone is low. That fat tissue releases IL-6, TNF-alpha, IL-1B, and leptin. These signals suppress the HPG axis and reduce the hormones that drive testosterone production. Together, these processes create a self-feeding cycle. In men with significant visceral fat, the aromatase enzyme also converts testosterone to estradiol at a higher rate, deepening the deficit.

For many men, low testosterone is partly a downstream result of chronic inflammation, not just a primary hormone problem. Treating only the hormonal side of this cycle has limited results on its own.

As a result, testosterone therapy alone does not fix the metabolic issues that drive elevated cytokines. In practice, weight loss and correcting hormone levels work better together. The Beyoung.Health article on losing weight with TRT covers how body composition and hormone recovery interact.

What Happens to Immune Markers on TRT

In Men With Hypogonadism and Metabolic Comorbidities

The clearest evidence comes from men who are both hypogonadal and metabolically compromised. Several trials show drops in CRP and TNF-alpha after correcting testosterone in this group. A 2025 systematic review linked TRT in hypogonadal men to lower TNF-alpha, reduced CRP, and better endothelial function.

The size of these reductions is, however, moderate. Nonetheless, TRT does not suppress cytokines the way anti-inflammatory drugs do. Rather, correcting the deficit removes one driver of elevated inflammation, letting other control systems work better.

In Men Without Hormonal Deficiency

TRT does not reliably reduce inflammation in men whose testosterone is already normal. The benefit in hypogonadal men comes from correcting a deficit. It does not come from above-normal testosterone acting as an anti-inflammatory drug.

Data on TRT’s effects in men with autoimmune conditions remains limited. Men with certain chronic inflammatory diseases show hypogonadism at higher rates. Still, no clear basis supports using TRT to treat autoimmune conditions. Correcting the hormone deficit is appropriate for that clinical reason. It does not replace disease-specific therapy.

Testosterone, Immune Aging, and Recovery

Inflammaging: The Background Fire of Aging

Inflammaging describes the chronic, low-grade inflammation that builds up as the immune system ages. It is not a sudden event. It is a slow, persistent rise in inflammatory activity. Over decades, it contributes to heart disease, insulin resistance, and neurodegeneration.

Indeed, testosterone declines with age, roughly in step with rising inflammaging markers. Immune cells carry androgen receptors. As testosterone falls, its effect on those cells weakens. This may add to rising inflammation in older men. A 2024 review identified several mechanisms involved, including immune cell aging and disrupted cytokine control in Leydig cells.

Keeping testosterone in the normal range may be one factor in managing inflammaging. Still, it is not a complete strategy on its own. Sleep, activity, diet, and stress all affect inflammation on their own, apart from hormone levels.

What TRT Can and Cannot Do

TRT does not make up for poor sleep or long-term inactivity. A man who corrects his hormone levels but neglects these factors will likely see limited improvement in inflammation. Men need to address lifestyle factors alongside therapy, not instead of it.

Musculoskeletal health is a related example. As covered in the Beyoung.Health article on low testosterone and joint pain, testosterone deficiency can contribute to joint discomfort through reduced cartilage support and higher local inflammation.

What This Means in Practice for Men on TRT

Men with confirmed hypogonadism and high background inflammation may see indirect immune-related benefits from correcting testosterone. This is most likely in men with excess visceral fat or metabolic syndrome, where the testosterone-inflammation feedback cycle is most active.

Generally, TRT is not prescribed for inflammation as a primary reason. If inflammatory markers remain high on TRT despite normal testosterone, that warrants a separate check. Relevant factors include diet, sleep quality, visceral fat, activity level, and possible underlying conditions.

Standard TRT monitoring does not routinely track cytokines or CRP. Routine lab follow-up focuses on testosterone levels, hematocrit, lipid profile, and PSA, among other parameters.

For a full overview of what supervised TRT involves, the Beyoung.Health page on testosterone replacement therapy outlines the process and clinical criteria.

Frequently Asked Questions

Q: Does Testosterone Reduce Inflammation?

Testosterone can reduce inflammatory cytokines, including TNF-alpha and IL-1B, in hypogonadal men. Notably, the effect is most evident in men with high baseline inflammation. It is real but moderate. Equating it with anti-inflammatory drug therapy, however, overstates the effect. In men with normal testosterone before treatment, this response is typically absent.

Q: Can Low Testosterone Cause Chronic Inflammation?

The relationship does not run in one direction. Low testosterone reduces androgen modulation of immune cell activity. This allows certain inflammatory pathways to become more active. At the same time, chronic inflammation from visceral fat suppresses the HPG axis and reduces testosterone output. Both processes feed each other, rather than forming a clean causal chain.

Q: Does TRT Affect the Immune System?

Yes, with some qualifications. Testosterone binds to androgen receptors on immune cells and affects cytokine output. In hypogonadal men, correcting testosterone can shift the immune profile toward less inflammatory activity. This is not the same as broadly strengthening immune defenses or improving resistance to infection.

Q: Can TRT Help With Autoimmune Conditions?

Research here remains limited. Notably, hypogonadism is more common in men with certain chronic inflammatory diseases. Still, no clear basis exists for using TRT to treat autoimmune conditions. In men with both confirmed hypogonadism and an autoimmune disease, treating the hormone deficit is appropriate for that clinical reason. It does not replace disease-specific therapy.

Q: What Happens to Inflammatory Markers on TRT?

In hypogonadal men with obesity or metabolic syndrome, some studies report drops in CRP and TNF-alpha after correcting testosterone. However, results vary across the broader hypogonadal population. The effect is inconsistent in leaner men with less baseline inflammation. It is absent in men whose testosterone was already normal before treatment. Standard TRT monitoring does not routinely track inflammatory markers.

This content is for informational purposes only and does not constitute medical advice. Consult a licensed nurse practitioner or licensed provider before starting or changing any treatment.